Five-year clinical and histologic results following treatment of human intrabony defects with an enamel matrix derivative combined with a natural bone mineral

International Journal of Periodontics and Restorative Dentistry

Volumn 28, Issue 2, 2008, Pages 153-161

  Sculean, Anton ^a   Chiantella, Giovanni Carlo ^a,b   Arweiler, Nicole Birgit ^c   Becker, Jürgen ^d   Schwarz, Frank ^d   Stavropoulos, Andreas ^e  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Department of Operative Dentistry and Periodontology ^*

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d Royal Dental College   (Germany)

^e UNIVERSITY OF AARHUS   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BIO OSS; BIO-OSS; ENAMEL MATRIX PROTEINS; ENAMEL PROTEIN; MINERAL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE DEVELOPMENT; BONE MATRIX; BONE PROSTHESIS; CHRONIC DISEASE; FEMALE; FOLLOW UP; GINGIVA DISEASE; HUMAN; LONGITUDINAL STUDY; MALE; MANDIBLE; MIDDLE AGED; OSTEOLYSIS; PATHOLOGY; PERIODONTAL DISEASE; PERIODONTICS; PERIODONTITIS; PHYSIOLOGY; TRANSPLANTATION; TREATMENT OUTCOME;

ADULT; AGED; ALVEOLAR BONE LOSS; BONE MATRIX; BONE SUBSTITUTES; CHRONIC DISEASE; DENTAL ENAMEL PROTEINS; FEMALE; FOLLOW-UP STUDIES; GINGIVAL RECESSION; GUIDED TISSUE REGENERATION, PERIODONTAL; HUMANS; LONGITUDINAL STUDIES; MALE; MANDIBLE; MIDDLE AGED; MINERALS; OSTEOGENESIS; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL POCKET; PERIODONTITIS; TREATMENT OUTCOME;

EID: 42249090376     PISSN: 01987569     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Karring T, Lindhe J, Cortellini P. Regenerative periodontal therapy. In: Lindhe J, Karring T, Lang NP (eds). Clinical Peri-odontology and Implant Dentistry. Copenhagen: Munksgaard, 1997:597-646.
2. Gestrelius S, Andersson C, Lidstrom D, Hammarström L, Sommerman M. In vitro studies on periodontal ligament cells and enamel matrix derivative. J Clin Periodontal 1997;24:685-692.
3. Van der Pauw MT, Van Den Bos T, Everts V, Beertsen W. Enamel matrix-derived protein stimulates attachment of periodontal ligament fibrablast and enhances alkaline phosphatase activity and transforming growth factor (31 release of periodontal ligament and gingival fibroblasts. J Periodontol 2000;71:31-43.
4. Hoang AM, Oates TW, Cochran DL In vitro wound healing responses to enamel matrix derivative. J Periodontol 2000;71:1270-1277.
5. Cattaneo V, Rota C, Silvestri M, et al. Effect of enamel matrix derivative on human periodontal fibroblasts: Proliferation, morphology and root surface colonization. An in vitro study. J Periodontal Res 2003;38:568-574.
6. Davenport DR, Mailhot JM, Wataha JC, Billman MA, Sharawy MM, Shrout MK. Effects of enamel matrix protein application on the viability, proliferation, and attachment of human periodontal ligament fibroblasts to diseased root surfaces in vitro. J Clin Periodontol 2003;30:125-131.
7. Lyngstadaas SP, Lundberg E, Ekdahl H, Andersson C, Gestrelius S. Autocrine growth factors in human periodontal ligament cells cultured on enamel matrix derivative. J Clin Periodontol 2001;28:181-188.
8. Okubo K, Kobayashi M, Takiguchi T, et al. Participation of endogenous IGF-I and TGF-beta 1 with enamel matrix derivative-stimulated cell growth in human periodontal ligament cells. J Periodontal Res 2003;38:1-9.
9. Keila S, Nemcovsky CE, Moses O, Artzi Z, Weinreb M. In vitro effects of enamel matrix proteins on rat bone marrow cells and gingiva! fibroblasts. J Dent Res 2004;83:134-138.
10. Kawase T, Okuda K, Yoshie H, Burns DM. Cytostatic action of enamel matrix derivative (EMDOGAIN) on human oral squamous cell carcinoma-derived SCC25 epithelial cells. J Periodontal Res 2000;35:291-300.
11. Suzuki S, Nagano T, Yamakoshi Y, et al. Enamel matrix derivative gel stimulates signal transduction of BMP and TGF-β. J Dent Res 2005;84:510-514.
12. Heijl L. Periodontal regeneration with enamel matrix derivative in one human experimental defect. A case report. J Clin Periodontol 1997;24:693-696.
13. Mellonig JT. Enamel matrix derivative for periodontal reconstructive surgery: Technique and clinical and histologic case report. Int J Periodontics Restorative Dent 1999;19:9-19.
14. Sculean A, Donos N, Windisch P, et al. Healing of human intrabony defects following treatment with enamel matrix proteins or guided tissue regeneration. J Periodontal Res 1999;34:310-322.
15. Yukna RA, Mellonig JT. Histologic evaluation of periodontal healing in humans following regenerative therapy with enamel matrix derivative. A 10-case series. J Periodontol 2000;71:752-759.
16. Sculean A, Chiantella GC, Windisch P, Donos N. Clinical and histologic evaluation of treatment of intrabony defects with an enamel matrix protein derivative (Emdogain). Int J Periodontics Restorative Dent 2000;20:375-381.
17. Bosshardt DD, Sculean A, Windisch P, Pietursson BE, Lang NP. Effects of enamel matrix proteins on tissue formation along the roots of human teeth. J Periodontal Res 2005;40:158-167.
18. Majzoub Z, Bobbo M, Atiyeh F, Cordioli G, Two patterns of histologic healing in an intrabony defect following treatment with an enamel matrix derivative: A human case report. Int J Periodontics Restorative Dent 2005;25:283-294.
19. Heijl L, Heden G, Svardstrom G, Ostgren A. Enamel matrix derivative (Emdogain) in the treatment of intrabony periodontal defects. J Clin Periodontol 1997;24:705-714.
20. Pontoriero R, Wennström J, Lindhe J. The use of barrier membranes and enamel matrix proteins in the treatment of angular bone defects. A prospective controlled clinical study. J Clin Periodontol 1999;26:833-840.
21. Froum SJ, Weinberg MA, Rosenberg E, Tarnow D. A comparative study utilizing open flap deridement with and witout enamel matrix derivative in the treatment of periodontal intrabony defects: A 12-month re-entry study. J Periodontol 2001;72:25-34.
22. Tonetti MS, Lang NP, Cortellini P, et al. Enamel matrix proteins in the regenerative therapy of deep intrabony defects. A multicenter randomized controlled clinical trial. J Clin Periodontol 2002;29:317-325.
23. Sculean A, Windisch P, Chiantella GC, Donos N, Brecx M, Reich E. Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. A prospective controlled clinical study. J Clin Periodontol 2001;28:397-403.
24. Zuchelli G, Bernardi F, Montebugnoli L, De Sanctis. Enamel matrix proteins and guided tissue regeneration with titanium-reinforced expanded polytetrafluoroeth-ylene membranes in the treatment of intrabony defects: A comparative controlled clinical trial. J Periodontol 2002;73:3-12.
25. Silvestri M, Sartori S, Rasperini G, Ricci G, Rota C, Cattaneo V. Comparison of intrabony defects treated with enamel matrix derivative versus guided tissue regeneration with a nonresorbable membrane. J Clin Periodontol 2003;30:386-393.
26. Sculean A, Donos N, Miliauskaite A, Arweiler N, Brecx M. Treatment of intrabony defects with enamel matrix proteins or bioresorbable membranes. A four-year follow-up split-mouth study. J Periodontol 2001;72:1695-1701.
27. Sanz M, Tonetti MS, Zabalegui I, et al. Treatment of intrabony defects with enamel matrix proteins or barrier membranes: Results from a multicenter practice-based clinical trial. J Periodontol 2004;75:726-733.
28. Sculean A, Windisch P, Keglevich T, Chiantella GC, Gera I, Donos N. Clinical and histologic evaluation of human intrabony defects treated with an enamel matrix protein derivative combined with a bovine-derived xenograft. Int J Periodontics Restorative Dent 2003;23:47-55.
29. Lekovic V, Camargo PM, Weinlaender M, Nedic M, Aleksic Z, Kenney BE. A comparison between enamel matrix proteins used alone or in combination with bovine porous bone mineral in the treatment of intrabony periodontal defects in humans. J Periodontol 2000;71:1695-1701.
30. Velasquez-Plata D, Scheyer ET, Mellonig JT Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans. J Periodontol 2002;73:433-440.
31. Zucchelli G, Amore C, Montebugnoli L, De Sanctis M. Enamel matrix proteins and bovine porous mineral in the treatment of intrabony defects: A comparative controlled clinical trial. J Periodontol 2003;74:1725-1735.
32. Loe H. The Gingival Index, the Plaque Index and the Retention Index system. J Periodontol 1967;38:610-616.
33. Tonetti MS, Pini Prato G, Cortellini P. Effect of cigarette smoking on periodontal healing following GTR in infrabony defects. A preliminary retrospective study. J Clin Periodontol 1995;22:229-234.
34. Camelo M, Nevins M, Schenk R, et al. Clinical, radiographic, and histologic evaluation of human periodontal defects treated with Bio-Oss and Bio-Gide. Int J Periodontics Restorative Dent 1998;18:321-331.
35. Mellonig J. Human histologic evaluation of a bovine-derived xenograft in the treatment of periodontal osseous defects. Int J Periodontics Restorative Dent 2000;20:19-29.
36. Camelo M, Nevins, ML, Lynch S, Schenk RK, Simion M, Nevins M. Periodontal regeneration with an autogenous bone-Bio-Oss composite graft and a Bio-Gide membrane. Int J Periodontics Restorative Dent 2001;21:109-119.
37. Sculean A, Stavropoulos A, Windisch P, Karring T, Gera I. Healing of human intrabony defects following regenerative periodontal therapy with a bovine-derived xenograft and guided tissue regeneration. Clin Oral Investig 2004;8:70-74.
38. Froum S, Lemler J, Horowitz R, Davidson B. The use of enamel matrix derivative in the treatment of periodontal osseous defects: A clinical decision tree based on biologic principles of regeneration. Int J Periodontics Restorative Dent 2001;21:437-449.
39. Simion M, Baldoni, M, Rossi P, Zaffe D. A comparative study of the effectiveness of e-PTFE membranes with and without early exposure during the healing period. Int J Periodontics Restorative Dent 1994;14:166-180.
40. Nowzari H, Matian F, Slots J. Periodontal pathogens on polytetrafuoroethylene membrane for guided tissue regeneration inhibit healing. J Clin Periodontol 1995;22:469-474.